Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
about
Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewIs There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?Hepatic radiation toxicity: avoidance and ameliorationRadioembolization of hepatic tumorsPilot study of angiogenic response to yttrium-90 radioembolization with resin microspheresQuantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolizationTherapy for metastatic pancreatic neuroendocrine tumors.Positron emission tomography image-guided drug delivery: current status and future perspectives.Quantitative and qualitative assessment of Yttrium-90 PET/CT imaging.Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolizationMulticenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.Research reporting standards for radioembolization of hepatic malignancies.Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumorsDiagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal CancersRadiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.Pharmacotherapy of Zollinger-Ellison syndrome.Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesThe value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesEvaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single CeTransarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature.Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up.The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes.Impact of dual-energy CT prior to radioembolization (RE).A new catheter for tumor targeting with radioactive microspheres in representative hepatic artery systems. Part I: impact of catheter presence on local blood flow and microsphere delivery.Quantitative Monte Carlo-based holmium-166 SPECT reconstruction.Predictive SIRT dosimetry based on a territorial model.Effectiveness of repeat angiographic assessment in patients designated for radioembolization using yttrium-90 microspheres with initial extrahepatic accumulation of technitium-99m macroaggregated albumin: a single center's experience.Aspects of images in magnetic resonance of liver tumors treated with transarterial selective internal radiotherapy with yttrium-90.Complete disappearance of uptake of FDG in the multifocal liver hemangioendothelioma after radioembolization therapy using yttrium-90 microspheres.Chemoembolic hepatopulmonary shunt reduction to allow safe yttrium-90 radioembolization lobectomy of hepatocellular carcinoma.
P2860
Q26772299-A79A77F8-ECFD-4F51-BD34-2568D521EBB9Q26796522-FA4A8422-7665-4F43-90E7-4B3309F97EF0Q27023687-085C9D32-4A4F-4509-A1A4-46F7E9262A61Q33820777-66A4B1F8-5FE0-4526-A7FB-53C619413927Q33867596-055DE563-94D5-4E72-A0B0-B99CD79A2E13Q34071529-1DB84944-C3F0-4D57-AD1C-E382708606D9Q34357869-2A20AF27-BE73-47E0-8131-F535590E50FCQ34446108-435FDDFD-5A3F-4318-9B2F-AEFE0FCF12B8Q34450157-ABFC3E18-9CA5-4E88-9DB7-96A2B77FC265Q34584472-6416BF82-9599-4F32-AF7B-A5E30B508FDDQ35028984-A2F882AA-23B8-4302-AD1A-FBBA6F4A7922Q35111887-E3532122-232C-49E6-B481-E924658E6939Q35227612-B54128AB-06F6-4870-976A-459398787ADDQ35570801-1C478786-9022-4967-BAD2-C2A2952FE595Q35843666-B589B63F-5B19-4FE9-9D5F-BD440D1ACA58Q35988578-48E1B074-49BF-47F5-B57E-36CDFD3D4B4AQ36632665-12A1ABF1-D77F-4FCF-8ADB-8D5E2CCEF68EQ36656612-26E2529E-B137-4F93-B682-E8E9136D3681Q37082835-C0467A7F-7AD9-4930-944A-06065D732E90Q37125550-2F1C3985-F85D-4E14-AF94-AE0EE019BE09Q37206772-764CB5B7-85C2-406E-8874-032D4EE05CA8Q38192781-726F1CA4-C6A2-44CA-9D0F-0CAF3E736644Q38246198-EC6D1592-93A7-4654-BA05-7B007C75ED64Q38621100-8975A90E-5054-476C-936B-1CDEF2231477Q40234961-6870DBC9-889A-4F66-AB49-DC8DE55C9F28Q44864991-C3172727-C121-47D0-BE0E-797F6A569C52Q45369216-A8E59771-8550-475B-979A-3D75B856E9A2Q47171915-E8AA792F-7CCE-4323-8DB5-61C3E3EE3823Q51540607-860B2AF4-C337-42C5-B569-1F8B06387146Q52740581-6DA82E66-F916-4737-AA82-A7374E598D0CQ53170109-BA86A113-CFF6-4966-B8CA-F22DE1AF818FQ53898689-84B4398F-2AEC-4C1C-9089-143E788310C4
P2860
Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radioembolization (yttrium-90 ...... tastatic hepatic malignancies.
@en
Radioembolization
@nl
type
label
Radioembolization (yttrium-90 ...... tastatic hepatic malignancies.
@en
Radioembolization
@nl
prefLabel
Radioembolization (yttrium-90 ...... tastatic hepatic malignancies.
@en
Radioembolization
@nl
P1433
P1476
Radioembolization (yttrium-90 ...... tastatic hepatic malignancies.
@en
P2093
Andrew S Kennedy
Riad Salem
P304
P356
10.1097/PPO.0B013E3181D7E8CF
P577
2010-03-01T00:00:00Z